New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 12, 2012
07:28 EDTSQNMSequenom upgraded to Buy from Hold at Jefferies
Jefferies upgraded Sequenom after its proprietary survey indicated the company is experiencing meaningful traction obtaining reimbursement coverage for its T21 laboratory developed test. The firm keeps a $7 price target for shares.
News For SQNM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 19, 2015
17:39 EDTSQNMSequenom launches the HerediT test in collaboration with Recombine
Sequenom's wholly owned subsidiary, Sequenom Laboratories, and Recombine Inc., a clinical genetic testing company dedicated to helping patients and providers make informed healthcare decisions, launched the HerediT UNIVERSAL carrier screening test as a service to ordering physicians. The HerediT UNIVERSAL test screens for more than 250 genetic diseases by analyzing over 2,000 genetic mutations.
07:59 EDTSQNMSequenom management to meet with William Blair
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use